Epigenetic analysis and drug development with cell-reprogramming technology in atypical teratoid/rhabdoid tumor
Grant-in-Aid for Scientific Research (C)
Basic Section 56010:Neurosurgery-related
Kyoto University
Yoshiki Arakawa
From 01 Apr. 2019, To 31 Mar. 2022, Project Closed
非定型奇形腫様ラブドイド腫瘍;リプログラミング;ヒト人工多能性幹細胞;エピゲノム異常;INI-1;SMARCB1;RAD21;iPS;AT/RT;転写ネットワーク;iPS;iPS細胞;エピゲノム